Published in QJM on November 10, 2009
Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort. PLoS One (2012) 1.25
Editorial neuroAIDS review. AIDS (2011) 1.10
Psychobiotics and the gut-brain axis: in the pursuit of happiness. Neuropsychiatr Dis Treat (2015) 0.95
Valproic acid-induced hyperammonemic encephalopathy - a potentially fatal adverse drug reaction. Springerplus (2013) 0.84
Gli1 activation and protection against hepatic encephalopathy is suppressed by circulating transforming growth factor β1 in mice. J Hepatol (2014) 0.83
Sodium benzoate for treatment of hepatic encephalopathy. Gastroenterol Hepatol (N Y) (2013) 0.82
Hepatic encephalopathy: an updated approach from pathogenesis to treatment. Med Sci Monit (2011) 0.81
Improvement of carbon tetrachloride-induced acute hepatic failure by transplantation of induced pluripotent stem cells without reprogramming factor c-Myc. Int J Mol Sci (2012) 0.80
Young-onset dementia. Semin Neurol (2013) 0.79
Bile Acid Signaling Is Involved in the Neurological Decline in a Murine Model of Acute Liver Failure. Am J Pathol (2015) 0.78
Deciphering the Developmental Dynamics of the Mouse Liver Transcriptome. PLoS One (2015) 0.78
Recurrent Acute Liver Failure Because of Acute Hepatitis Induced by Organic Solvents: A Case Report. Medicine (Baltimore) (2016) 0.77
Fractalkine suppression during hepatic encephalopathy promotes neuroinflammation in mice. J Neuroinflammation (2016) 0.75
Effects of bile acids on neurological function and disease. FASEB J (2016) 0.75
MRI/DTI of the Brain Stem Reveals Reversible and Irreversible Disruption of the Baroreflex Neural Circuits: Clinical Implications. Theranostics (2016) 0.75
Management of hepatic encephalopathy by traditional chinese medicine. Evid Based Complement Alternat Med (2012) 0.75
Modern progress in hepatic encephalopathy. QJM (2010) 0.75
Nitrosative Stress-Induced Disruption of Baroreflex Neural Circuits in a Rat Model of Hepatic Encephalopathy: A DTI Study. Sci Rep (2017) 0.75
Creutzfeldt-Jakob Disease: Analysis of Four Cases. Front Neurol (2016) 0.75
Clinical profile, natural history, and predictors of mortality in patients with acute-on-chronic liver failure (ACLF). Wien Klin Wochenschr (2015) 0.75
Manganese toxicity in critical care: Case report, literature review and recommendations for practice. J Intensive Care Soc (2015) 0.75
Lactulose decreases neuronal activation and attenuates motor behavioral deficits in hyperammonemic rats. Metab Brain Dis (2017) 0.75
COX 2 inhibitor and fulminant hepatic failure. Lancet (1999) 3.80
Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res (2000) 3.41
Hepatitis B virus infection in medical and health care personnel. Br Med J (Clin Res Ed) (1982) 2.85
Test liquids for quantitative MRI measurements of self-diffusion coefficient in vivo. Magn Reson Med (2000) 2.14
Postpartum coma. Lancet (1998) 2.07
High morbidity expected from cirrhosis in injecting drug users. Ir Med J (2004) 2.03
Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology (1990) 2.02
Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. Clin Exp Immunol (1984) 1.67
Telephone reminders to reduce non-attendance rate for endoscopy. J R Soc Med (2003) 1.62
Anticentromere antibody in primary biliary cirrhosis. Ann Rheum Dis (1982) 1.53
Diurnal pattern of variceal bleeding in cirrhotic patients. J Hepatol (1993) 1.47
High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer. Int J Cancer (1999) 1.40
Staple-line erosion: a common source of recurrent bleeding following stapled oesophageal transection. Br J Surg (1991) 1.39
Needle-localised biopsy of impalpable breast lesions: a novel adjunct to surgical technique and specimen mammography. Surgeon (2004) 1.39
LeVeen shunt with wandering tip. Lancet (1991) 1.36
Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer. Int J Cancer (1995) 1.35
Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm Res (2001) 1.33
Acute renal disease, as defined by the RIFLE criteria, post-liver transplantation. Am J Transplant (2006) 1.25
Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease. J Vasc Surg (1998) 1.21
Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates. Hepatology (1989) 1.21
Influence of spinal and general anaesthesia on haemostasis during total hip arthroplasty. Br J Anaesth (1987) 1.20
Overexpression of the Ets-1 transcription factor in human breast cancer. Br J Cancer (2004) 1.20
Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy. HIV Med (2006) 1.19
High levels of TIMP-2 correlate with adverse prognosis in breast cancer. Int J Cancer (2000) 1.16
The educational value of being a house surgeon. Med Educ (1985) 1.13
Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors. Int J Cancer (2000) 1.12
Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer. Br J Cancer (2005) 1.12
Bleeding time in patients with hepatic cirrhosis. BMJ (1990) 1.10
Severe pain confounds neuropsychological test performance. J Clin Exp Neuropsychol (2000) 1.10
Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer. Br J Cancer (1998) 1.07
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer. Br J Cancer (1995) 1.03
Interaction of antigen presenting cells with mycobacteria. Vet Immunol Immunopathol (2004) 1.02
A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation. J Hepatol (1993) 1.00
Anti-human epidermal growth factor receptor 2 monoclonal antibody therapy for breast cancer. Br J Surg (2002) 0.98
Remission induction in refractory Crohns disease using a high calorie whole diet. JPEN J Parenter Enteral Nutr (1989) 0.97
CA 15-3: a prognostic marker in breast cancer. Int J Biol Markers (2001) 0.96
High incidence of the Cys 282 Tyr mutation in the HFE gene in the Irish population--implications for haemochromatosis. Tissue Antigens (1998) 0.95
Prognostic significance of the white nipple sign in variceal bleeding. Gastrointest Endosc (1991) 0.94
Urokinase plasminogen activator as a prognostic marker in different subgroups of patients with breast cancer. Cancer (1994) 0.94
Crohn's colitis and sarcoidosis. Postgrad Med J (1986) 0.94
MELD score as a prognostic model for listing acute liver failure patients for liver transplantation. Transplant Proc (2006) 0.94
Ets2 transcription factor in normal and neoplastic human breast tissue. Eur J Cancer (2005) 0.93
Zinc absorption in alcoholics using zinc-65. Digestion (1985) 0.93
Natural history and prognosis of variceal bleeding. Baillieres Clin Gastroenterol (1992) 0.93
Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome. Visual prognosis. Ophthalmology (1984) 0.92
Antioxidant status and lipid peroxidation in hereditary haemochromatosis. Free Radic Biol Med (1994) 0.92
High prevalence of celiac sprue among patients with primary biliary cirrhosis. J Clin Gastroenterol (1997) 0.92
Adult "idiopathic" extrahepatic venous thrombosis. Importance of putative "latent" myeloproliferative disorders and comparison with cases with known etiology. Dig Dis Sci (1992) 0.92
Monensin, a new biologically active compound. VI. Anticoccidial activity. Antimicrob Agents Chemother (Bethesda) (1967) 0.92
Acute colonic obstruction due to benign prostatic hypertrophy. Ir Med J (2009) 0.91
Both under-nutrition and obesity increase morbidity following liver transplantation. Ir Med J (2003) 0.91
Plasminogen activator inhibitor type 2 in breast cancer. Br J Cancer (1997) 0.90
Diversity of autoantibodies in patients with antimitochondrial antibody and their diagnostic value. J Clin Pathol (1987) 0.90
Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological, and clinical findings. Clin Chem (1991) 0.89
Predictive testing for BRCA1 and 2 mutations: a male contribution. Ann Oncol (2003) 0.89
Peptic ulcer in rheumatoid arthritis--intrinsic or related to drug therapy? Br J Rheumatol (1986) 0.88
A case of hepatoma associated with hypoglycaemia and overproduction of IGF-II (E-21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin. Clin Endocrinol (Oxf) (1994) 0.88
Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration. Oncol Rep (2005) 0.88
Interstitial pneumonitis associated with sirolimus (rapamycin) therapy after liver transplantation. Transplantation (2001) 0.88
Protein kinase Cdelta expression in breast cancer as measured by real-time PCR, western blotting and ELISA. Br J Cancer (2008) 0.87
Making sense of dying: a review of narratives written since 1950 by people facing death from cancer and other diseases. Palliat Med (2006) 0.87
Somatostatin and octreotide in gastroenterology. Aliment Pharmacol Ther (1991) 0.86
Antibiotic pharmacoeconomics: an attempt to find the real cost of hospital antibiotic prescribing. Ulster Med J (1993) 0.86
Acute fatty liver of pregnancy and diagnosis by computed tomography. Br Med J (Clin Res Ed) (1986) 0.86
Cyclooxygenase-2 predicts adverse effects of tamoxifen: a possible mechanism of role for nuclear HER2 in breast cancer patients. Endocr Relat Cancer (2008) 0.86
The role of oestrogen receptor {alpha} in human thyroid cancer: contributions from coregulatory proteins and the tyrosine kinase receptor HER2. Endocr Relat Cancer (2010) 0.86
Physician's initial impression of elderly breast cancer patients allows appropriate treatment stratification despite lack of quantitative assessment. Ir Med J (2011) 0.85
Urokinase plasminogen activator as a predictor of aggressive disease in breast cancer. Enzyme Protein (1996) 0.85
Adjuvant therapy used in conjunction with combination therapy for chronic hepatitis C improves sustained virus response rates in genotype 1 patients. J Viral Hepat (2009) 0.85
Postanesthetic carbimazole jaundice. N Engl J Med (1983) 0.85
Erythropoietic protoporphyria and iron therapy. Br J Dermatol (1990) 0.84
Late-onset CMV disease following CMV prophylaxis. Ir J Med Sci (2009) 0.84
Pancreatitis in sarcoidosis. Br Med J (Clin Res Ed) (1985) 0.84
Postprandial changes in portal haemodynamics in patients with cirrhosis. Gut (1992) 0.83
Endoscopic detection of ischaemia with a new probe indicates low oxygenation of gastric epithelium in portal hypertensive gastropathy. Gut (1995) 0.83
Disordered vascular compliance in haemochromatosis. Ir J Med Sci (2013) 0.83
Granulomatous appendicitis revisited: report of a case. Dig Surg (2001) 0.82
Budd-Chiari syndrome treated with acylated streptokinase-plasminogen complex. J R Soc Med (1985) 0.82
Status epilepticus and near hanging. Postgrad Med J (1985) 0.82
CEA and CA 15-3 in primary and recurrent breast cancer. World J Surg (1990) 0.82
Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes. Gut (2013) 0.82
Juvenile transient global amnesia. J Neurol Neurosurg Psychiatry (1983) 0.81
Alcohol misuse in patients with psoriasis: identification and relationship to disease severity and psychological distress. Br J Dermatol (2011) 0.81
Rapidly progressive obstructive jaundice due to Congo red negative amyloidosis. Ulster Med J (1991) 0.80
Rapid, early and sustained virological responses in a cohort of Irish patients treated with pegylated interferon and ribavirin for chronic hepatitis C virus infection. Ir J Med Sci (2011) 0.80
L-155,175: a new antiparasitic macrolide. Fermentation, isolation and structure. J Antibiot (Tokyo) (1985) 0.80
Multiple drug resistance-related messenger RNA expression in archival formalin-fixed paraffin-embedded human breast tumour tissue. Eur J Cancer (1996) 0.79
A practical guide to the management of oesophageal varices. Drugs (1999) 0.79
The significance of immunohistochemistry positivity in sentinel nodes which are negative on haematoxylin and eosin in breast cancer. Eur J Surg Oncol (2009) 0.79
47 years of phaeochromocytomas. Ir Med J (2001) 0.79
Early experience with chronic hepatitis C in Northern Ireland: epidemiology and response to monotherapy. Ulster Med J (2004) 0.79
Postpartum aHUS secondary to a genetic abnormality in factor H acquired through liver transplantation. Am J Transplant (2012) 0.79
Liver/spleen scintigraphy for diagnosis of splenic infarction in cirrhotic patients. Postgrad Med J (1993) 0.79
An in vitro model of aneurysmal disease: effect of leukocyte infiltration and shear stress on MMP production within the arterial wall. Ann N Y Acad Sci (1996) 0.79
Gold induced colitis: case report and literature review. Ir Med J (1985) 0.79
Liver transplantation and primary biliary cirrhosis. Postgrad Med J (1989) 0.78
Small bowel telangiectasia in scleroderma. Ann Rheum Dis (1995) 0.78
Anticoccidial drugs: screening methods. Exp Parasitol (1970) 0.78